New legislative proposals from the European Commission aim to reinforce cooperation among EU member states on health technology assessments (HTAs), including mandatory cooperation in joint clinical assessments, scientific dialogues, horizon scanning and voluntary cooperation in other areas. The proposals, which apply to innovative products, are a “positive step,” according to EFPIA, the European Federation of Pharmaceutical Industries and Associations.
Currently different member states have different procedures for HTA, which means a lack of predictability and higher costs for companies, delays in access for patients, duplication of work and inefficient use of resources for the numerous national and regional HTA bodies
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?